Global Influenza Market - Expected to Increase from $5.4 Billion in 2016 to $6.4 Billion in 2021 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "The Global Influenza Market" report to their offering.

The report includes an overview of the global market for influenza vaccines, therapeutics, and diagnostics. It provides analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021. Information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers are also given, with a special emphasis on U.S. and European markets.

The report contains discussion of efforts by government agencies and disease prevention organizations to support and fund research and development programs, and pandemic prevention. It covers market's dynamics, specifically growth drivers, restraints, and opportunities. There are also company profiles of major players in the industry.

This report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. and European data. The report identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.

Companies Mentioned

  • Alere Inc.
  • Astrazeneca/Medimmune
  • Becton Dickinson And Company
  • Cepheid
  • Daiichi Sankyo
  • Glaxosmithkline Plc
  • Hologic Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Mylan N.V.
  • Orasure Technologies
  • Protein Sciences Corporation
  • Qiagen N.V.
  • Quidel Corp.
  • Roche Ltd.
  • Sanofi/Sanofi Pasteur
  • Sekisui Diagnostics Llc
  • Seqirus CSL Limited

Key Topics Covered:

1: Introduction

2: Summary

3: Industry Overview

4: Issues Affecting The Market

5: Patent Analysis

6: Influenza Vaccines

7: Influenza Therapies

8: Influenza Diagnostics

9: Influenza Market Summary

10: Company Profiles

11: Appendices

For more information about this report visit http://www.researchandmarkets.com/research/2xdh85/the_global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs